Evaluation of the efficacy of topical ethyl vanillate in treatment of vitiligo
Not Applicable
- Conditions
- vitiligo.Vitiligo
- Registration Number
- IRCT201107317160N1
- Lead Sponsor
- Vice chancellor for research, Shiraz university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Pateints with bilateral generalized depigmented lesions are selected among phototherapy patients. Pregnant women, children under 6 years of age, patients with past history of skin cancer, and patients taking immunosuppresive medications, are excluded from study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pigmentation of lesions. Timepoint: before intervention 1, 2, 3 months after intervention. Method of measurement: vitiligo area severity index scale.
- Secondary Outcome Measures
Name Time Method Erythema of lesion. Timepoint: at the end of months 1, 2, 3 after intervention. Method of measurement: taking photo.